.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
McKinsey
US Army
Covington
Healthtrust
Cipla
Cerilliant
Baxter
Daiichi Sankyo

Generated: June 26, 2017

DrugPatentWatch Database Preview

Estropipate - Generic Drug Details

« Back to Dashboard

What are the generic sources for estropipate and what is the scope of estropipate patent protection?

Estropipate
is the generic ingredient in seven branded drugs marketed by Pharmacia And Upjohn, Watson Labs, Watson Labs Teva, Barr, Mylan, Sun Pharm Inds Inc, and Duramed Pharms Barr, and is included in eleven NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for estropipate. Three suppliers are listed for this compound.

Summary for Generic Name: estropipate

Tradenames:7
Patents:1
Applicants:7
NDAs:11
Drug Master File Entries: see list2
Suppliers / Packagers: see list3
Bulk Api Vendors: see list29
Patent Applications: see list2,660
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Drug Prices:see low prices
DailyMed Link:estropipate at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Barr
ESTROPIPATE
estropipate
TABLET;ORAL040135-002Nov 27, 1996DISCNNoNo► Subscribe► Subscribe
Watson Labs
ESTROPIPATE
estropipate
TABLET;ORAL081214-001Sep 23, 1993ABRXNoNo► Subscribe► Subscribe
Pharmacia And Upjohn
OGEN
estropipate
CREAM;VAGINAL084710-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Barr
ESTROPIPATE
estropipate
TABLET;ORAL040135-001Nov 27, 1996DISCNNoNo► Subscribe► Subscribe
Duramed Pharms Barr
ESTROPIPATE
estropipate
TABLET;ORAL040296-001Nov 1, 1999DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Cerilliant
Mallinckrodt
Accenture
Federal Trade Commission
Chinese Patent Office
Express Scripts
US Department of Justice
Fuji
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot